Login

Anthem Biosciences Ltd.

₹724.5

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Anthem Biosciences Ltd.

  • NSE : ANTHEM
Add Alert
Add Watchlist

₹724.5

₹724.5

-12.2 (-1.66%) - 6 Aug 2025 04:25 PM
  • NSE : ANTHEM

About Company

Anthem Biosciences is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing with integrated New Chemical Entity (NCE) and New Biological Entity (NBE) capabilities across drug discovery, development, and commercial manufacturing.

Market Cap. ₹ 40,689 Cr.
52 Week - High/Low ₹ 802/702
P/E Ratio N/A
P/B Ratio 16.73
Enterprise Value ₹ 41,116 Cr.
ROE % 23.16
RSI Value 84.80
EMA 50 738.32
EMA 200 732.81
Market Cap. ₹ 40,689 Cr.
52 Week - High/Low ₹ 802/702
P/E Ratio N/A
P/B Ratio 17.17
Enterprise Value ₹ 41,110 Cr.
ROE % 20.99
RSI Value 84.80
EMA 50 738.32
EMA 200 732.81
Add Parameters

Growth

Chart Icon
View Full Chart

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Quarterly

Yearly

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.